Literature DB >> 19217653

Multiallergen immunotherapy for allergic rhinitis and asthma.

Harold S Nelson1.   

Abstract

The English and non-English language literature on allergen immunotherapy was reviewed for studies simultaneously using 2 or more distinct allergen extracts in either subcutaneous or sublingual immunotherapy. Thirteen studies were identified, 11 using subcutaneous injections, 1 using sublingual administration, and 1 using both. In studies with adequate information, administration of 2 extracts by means of either subcutaneous immunotherapy or sublingual immunotherapy was effective. In studies using multiple allergens, 3 studies showed clear efficacy, whereas in the other 2 studies, lack of efficacy might have been due to inadequate doses of extract or omission of clinically relevant allergens in the treatment regimen. It is concluded that simultaneous administration of more than 1 allergen extract is clinically effective. However, more studies are needed, particularly with more than 2 allergen extracts and with sublingual administration.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19217653     DOI: 10.1016/j.jaci.2008.12.013

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  15 in total

Review 1.  Subcutaneous and sublingual immunotherapy for allergic rhinitis: what is the evidence?

Authors:  Sarah K Wise; Rodney J Schlosser
Journal:  Am J Rhinol Allergy       Date:  2012 Jan-Feb       Impact factor: 2.467

2.  Forkhead box P3+ T cells express interleukin-17 in nasal mucosa of patients with both allergic rhinitis and polyposis.

Authors:  T Liu; C-H Song; A-M Liu; C Xie; F Zhao; X Chen; L Cheng; P-C Yang
Journal:  Clin Exp Immunol       Date:  2010-11-22       Impact factor: 4.330

3.  Allergen immunotherapy in allergic respiratory diseases: from mechanisms to meta-analyses.

Authors:  Ravi K Viswanathan; William W Busse
Journal:  Chest       Date:  2012-05       Impact factor: 9.410

4.  Epigenetic modifications and improved regulatory T-cell function in subjects undergoing dual sublingual immunotherapy.

Authors:  Ravi S Swamy; Neha Reshamwala; Tessa Hunter; Soujanya Vissamsetti; Carah B Santos; Fuad M Baroody; Peter H Hwang; Elisabeth G Hoyte; Marco A Garcia; Kari C Nadeau
Journal:  J Allergy Clin Immunol       Date:  2012-06-05       Impact factor: 10.793

5.  Quality of life improvement with sublingual immunotherapy: a prospective study of efficacy.

Authors:  Mary S Morris; Amanda Lowery; Demetrios S Theodoropoulos; R Daniel Duquette; David L Morris
Journal:  J Allergy (Cairo)       Date:  2012-01-30

6.  The efficacy assessment of a self-administered immunotherapy protocol.

Authors:  Frederick M Schaffer; Larry M Garner; Myla Ebeling; Jeffrey M Adelglass; Thomas C Hulsey; Andrew R Naples
Journal:  Int Forum Allergy Rhinol       Date:  2015-10-14       Impact factor: 3.858

Review 7.  Allergen-specific immunotherapy in pediatric allergic asthma.

Authors:  Ayfer Yukselen
Journal:  Asia Pac Allergy       Date:  2016-07-28

8.  Effect on quality of life of the mixed house dust mite/weed pollen extract immunotherapy.

Authors:  Lisha Li; Kai Guan
Journal:  Asia Pac Allergy       Date:  2016-07-28

9.  Trends in Specific Immunotherapy for Allergic Rhinitis: A Survey of Chinese ENT Specialists.

Authors:  Han Zhou; Qi-Lei Tao; Jun-Min Wei; Geng Xu; Lei Cheng
Journal:  Allergy Asthma Immunol Res       Date:  2014-02-13       Impact factor: 5.764

10.  Current specific immunotherapy for allergic rhinitis: perspectives from otorhinolaryngologists.

Authors:  Chae-Seo Rhee
Journal:  Allergy Asthma Immunol Res       Date:  2014-06-19       Impact factor: 5.764

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.